These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16107196)

  • 1. Anti-MRSA agents: under investigation, in the exploratory phase and clinically available.
    Bryskier A
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):505-53. PubMed ID: 16107196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methicillin-resistant Staphylococcus aureus (MRSA) -- case report].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):581; quiz 589-92. PubMed ID: 15761786
    [No Abstract]   [Full Text] [Related]  

  • 6. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL
    Semin Pediatr Infect Dis; 2006 Jul; 17(3):113-9. PubMed ID: 16934705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
    [No Abstract]   [Full Text] [Related]  

  • 8. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of staphylococcal resistance.
    Shorr AF
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S171-6. PubMed ID: 17712743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Rubinstein E; Kollef MH; Nathwani D
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003.
    Klevens RM; Edwards JR; Tenover FC; McDonald LC; Horan T; Gaynes R;
    Clin Infect Dis; 2006 Feb; 42(3):389-91. PubMed ID: 16392087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report.
    Orrett FA
    Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611
    [No Abstract]   [Full Text] [Related]  

  • 19. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.